Výsledky vyhledávání

The GISS Trial: a Phase II Prevention Trial of Screening Plus Goserelin, Ibandronate, versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer

Autor: Caroline Nestle-Kraemling, Stefan Paepke, Gunter von Minckwitz, Sibylle Loibl, Nico Maass, Manfred Kaufmann, Diethelm Wallwiener, Christian Jackisch, S. Vescia, Rita K. Schmutzler, K. Budischewski, Michael P. Lux, Andreas du Bois

Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 20:2141-2149

Background: Genetic testing for inherited mutations in breast cancer genes provides valuable information for disease prevention. Today, premenopausal women with increased risk for breast cancer have only limited nonsurgical options to reduce their ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5d3785c3d9c8006e2fb902e3d5e096
https://doi.org/10.1158/1055-9965.epi-11-0222

Zobrazit plný text záznamu

Management of venous port systems in oncology: a review of current evidence

Autor: Marion Kiechle-Bahat, A. K. Baumgärtner, S. Loibl, S. Vescia, Achim Rody, Volker R. Jacobs, Nadia Harbeck

Publikováno v: Annals of Oncology. 19:9-15

Over the last decades, many changes have occurred in oncology with new chemotherapy combinations and more complex application schemes becoming available. Central venous catheters and implantable venous port systems have become widely used and have fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cc59c423a42b70bfaec000156b80b7
https://doi.org/10.1093/annonc/mdm272

Zobrazit plný text záznamu

[η3-methallyl-nickel-dad]PF6 complex: new catalyst precursor for ethylene polymerization

Autor: Leonardo C. Simon, Roberto-F. De Souza, Daniela V. S. Vescia, Fernanda Nunes, Raquel Santos Mauler, Alessandro Cavagnolli

Publikováno v: Macromolecular Rapid Communications. 18:795-800

SUMMARY The complex [q3-methallyl-nickel-dad]PF6 is a new catalyst precursor for ethylene polymerization. The system is active in the presence of usual organoaluminium compounds like diethylaluminium chloride, at low AUNi ratios and under mild reacti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b37e98876346638e012947a74d3c836b
https://doi.org/10.1002/marc.1997.030180907

Zobrazit plný text záznamu

Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study

Autor: Wolfgang Eiermann, G. von Minckwitz, A. du Bois, Sherko Kümmel, Bernd Gerber, Jörn Hilfrich, S. Vescia, S. Loibl, C. Jackisch, Serban-Dan Costa, H. Eidtmann, Keyur Mehta, T. Skacel, J Huober, Manfred Kaufmann, S. T. Grasshoff

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 19(2)

BACKGROUND TAC (docetaxel/doxorubicin/cyclophosphamide) is associated with high incidences of grade 4 neutropenia and febrile neutropenia (FN). This analysis compared the efficacies of four regimens for primary prophylaxis of FN and related toxic eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8bd095959e3fb5820abda0a71b3265
https://pubmed.ncbi.nlm.nih.gov/17846019

Zobrazit plný text záznamu

A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93

Autor: Ute-Susann Albert, B. Conrad, Walter Jonat, Sibylle Loibl, Erika Graf, Martin Schumacher, Wolfgang Eiermann, Manfred Kaufmann, Günther Gademann, Gunter von Minckwitz, M. Geberth, S. Vescia

Publikováno v: European journal of cancer (Oxford, England : 1990). 43(16)

GABG-IV B-93 is a prospective, randomised study comparing goserelin (n=384) with no further treatment (n=392) in hormone receptor (HR)-negative breast cancer patients (n=465) after 3 cycles cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226124972324b6e51d62b287a9ff8041
https://pubmed.ncbi.nlm.nih.gov/17897821

Zobrazit plný text záznamu

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)

Autor: Erika Graf, K. Brunnert, Manfred Kaufmann, Wolfgang Eiermann, B. Conrad, Walter Jonat, Bernd Gerber, S. Vescia, Gunter von Minckwitz, M. Geberth, Jörg Wollert

Publikováno v: European journal of cancer (Oxford, England : 1990). 42(12)

Gonadotrophin-releasing hormone analogues were investigated as adjuvant treatment for patients with node-negative, hormone-sensitive, premenopausal breast cancer. Patients were randomised to either three cycles of cyclophosphamide, methotrexate, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bdf47d796d4d723e008bf298949fcef
https://pubmed.ncbi.nlm.nih.gov/16765589

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání